Skip to main content
logo
Genix Pharmaceuticals Corporation (TSXV:GENX)
Canada flag Canada · Delayed Price · Currency is CAD
0.0200
0.00 (0.00%)
At close: Aug 21, 2026

Genix Pharmaceuticals Cash Flow Statement

Millions CAD. Fiscal year is Nov - Oct.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Net Income
-0.31-0.34-0.07-4.4-1.07-1.65
Depreciation & Amortization
---0.550.560.54
Other Amortization
000000
Asset Writedown & Restructuring Costs
0.010.01-3.46--
Stock-Based Compensation
--0.030.060.260.81
Other Operating Activities
0.180.17-0.170.060.040
Change in Accounts Receivable
00-00.02-0.010
Change in Inventory
---00.01-0.17-0
Change in Accounts Payable
0.010.010.040.030.18-0.09
Change in Other Net Operating Assets
0.010.02-0-0-0-0.03
Operating Cash Flow
-0.1-0.12-0.19-0.22-0.22-0.43
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Sale (Purchase) of Intangibles
-----0-
Investing Cash Flow
-----0-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Short-Term Debt Issued
-0.090.190.280.17-
Total Debt Issued
0.040.090.190.280.17-
Long-Term Debt Repaid
--0.03---0.02-0.01
Total Debt Repaid
-0.03-0.03---0.02-0.01
Net Debt Issued (Repaid)
0.010.060.190.280.15-0.01
Issuance of Common Stock
0.10.1----
Other Financing Activities
-0-0--0.06-0.05-0.12
Financing Cash Flow
0.110.160.190.220.09-0.13

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Foreign Exchange Rate Adjustments
-0.01-----
Net Cash Flow
0.010.03-00-0.13-0.56

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Free Cash Flow
-0.1-0.12-0.19-0.22-0.22-0.43
Free Cash Flow Growth
------
Free Cash Flow Margin
---4624.54%-1787.27%--
Free Cash Flow Per Share
-0.00-0.00-0.00-0.00-0.00-0.01
Levered Free Cash Flow
-0.16-0.15-0.530.060.170.68
Unlevered Free Cash Flow
-0.05-0.04-0.460.090.180.68

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Cash Interest Paid
----0-
Change in Working Capital
0.020.030.030.06-0.01-0.12